✦ LIBER ✦

Cisplatin + etoposide (CE) versus CE alternated with cyclophosphamide + epirubicin + teniposide (EVE) in small cell lung cancer (SCLC)

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cisplatin-VP16 alternating with cyclopho

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Cisplatin and etoposide versus cyclophos

✍ Veronesi, A.; Cartel, G.; CriveUari, D.; Magri, M.D.; Valentina, M.Delia; Folado 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 595 KB

Cisplatin and etoposide versus cyclophos

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 147 KB

Carboplatin and etoposide (CE) in newly

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 109 KB

Etoposide-cisplatin (EP) versus four-dru

✍ Pujol, J; Daures, J; Riviere, A; Quoix, E; Depierre, A; Breton, J.L; Lemarie, E; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 112 KB

A phase II study of cyclophosphamide / a

✍ Hara, N.; Ichinose, Y.; Kuba, M.; Ichikawa, Y.; Ninomiya, K.; Shima, K.; Yamamot 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 162 KB